We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hutchmed (china) Limited | LSE:HCM | London | Ordinary Share | KYG4672N1198 | ORD USD0.10 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
3.00 | 1.13% | 267.50 | 265.00 | 267.00 | 273.00 | 265.50 | 266.50 | 18,840 | 16:35:28 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 838M | 100.78M | - | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
17/3/2016 21:12 | Can anyone say why we actually needed the ipo? Presumably Hcm doesn't need the cash? Feel slightly aggrieved that a) my holding has plummeted in value (although I'm more likely to,buy more than sell) and b) we're now exposed to the US mkt and tribulations of fx arbitrage. | cisk | |
17/3/2016 17:25 | It's a quality company with huge prospects but I can't understand the logic of the ADS price. Sold my last tranche this morning (luckily) as I think the whole US market is going to tank which will drag good and bad down with it. The QE experiment is quickly unfolding so have been topping up my gold!! | essential | |
17/3/2016 16:36 | We got shafted. | nhb001 | |
17/3/2016 16:01 | Maybe but the stock is in very choppy sector waters in an uncertain market.Moreover the sizeable placing discount does nothing to dismiss suggestions that the biotech sector might weaken further before things get better. | steeplejack | |
17/3/2016 15:44 | makes me wonder why the IPO has taken so long when originally filed 5 months ago I wonder if they've been delaying it due to market conditions and the discount and finally gave in. Not good but I do not think it will stay at this market cap for very long, there's far too much upside and news to come this year | nerdofsteel | |
17/3/2016 15:17 | For sure,so it's a bit of a mystery why the AIM quote held up so well,this morning.I'm surprised that the company proceeded with the issue at this time.Ordinarily,you' | steeplejack | |
17/3/2016 15:01 | It was always going to be arbitraged. They offered a 15% discount. | nhb001 | |
17/3/2016 14:39 | Just the biotech sector is well out of favour helped by sound bites in US election year.Unless the company comes out with good news pronto,looks like the stock will equalise around the placing price.The US institutions drove a hard bargain when it came to pricing the offer and if the other bulletin boards are anything to go by,it's caught the punters out.Of course,the placing is quite sizeable in increasing the free equity outside of the Hutchinson interest. | steeplejack | |
17/3/2016 14:31 | maybe we should change our name - clearly the word China puts off many U.S. Investors | nerdofsteel | |
17/3/2016 10:32 | The price reaction today suggests you might be right.They're holding up well. | steeplejack | |
17/3/2016 07:34 | I think that explains the sharp drop in share price some weeks back.The intended pricing of the ADSs must of leaked out.An equivalent London price of £19.42 is a sizeable discount to the existing AIM price.I'd be surprised if we didn't see a few taking a quick profit in the US.Maybe,it was optimistic but I thought (especially given you can get a slug of stock)they might get this placing away at nearer the AIM price ie £22-50 odd.Not to be.I can see them doing the greenshoe,additional placing,in full.Who the hell wouldn't want to go for that at a discount to the London price of getting on for 15%!Nonetheless,they "7,500,000 ADSs were sold in the Offering at a price of US$13.50 per ADS, and the offering price is thus equivalent to approximately GBP19.42 per ordinary share (on the basis of an assumed exchange rate as quoted in the preliminary prospectus of GBP1.00 to US$1.39). Each ADS represents one-half of one ordinary share of Chi-Med. The ADSs have been approved for listing on the Nasdaq Global Select Market and are expected to begin trading on March 17, 2016 under the ticker symbol "HCM." Chi-Med's ordinary shares will continue to be traded on the AIM market of the London Stock Exchange following the Offering under the ticker symbol "HCM." | steeplejack | |
16/3/2016 11:11 | Big day tomorrow, massive fundraise that is not dilutive and will help us to push several drug candidates over the line. Moving ever closer towards revenues measured in billions rather than millions | nerdofsteel | |
16/3/2016 10:40 | Bit of buying today ahead of listing in us | aim999 | |
15/3/2016 11:23 | Over $100m in the bank on Thursday, followed quickly by major pipeline news I suspect | nerdofsteel | |
10/3/2016 21:27 | Its a great sign of the appetite for our company in the US. Exciting times! | twonky | |
10/3/2016 18:45 | I don't think so.I think the size of the greenshoe as its called,a reserve allotment,has to be agreed in advance.Anyway,from our point of view,better to leave US investors hungry! | steeplejack | |
10/3/2016 16:46 | Can they sell more then the 15%? | twonky | |
10/3/2016 15:37 | 3/8/2016 9:30:18 AM Hutchison China MediTech (Chi-Med), a company developing novel drugs for oncology and autoimmune diseases, is scheduled to raise $100 million by listing ADS shares on the NASDAQ exchange. The offering values Chi-Med at almost $1 billion. Each ADS will be equal to one-half of each London-traded Chi-Med share. Chi-Med will issue 6.1 million ADSs at a price to be determined by demand, though it will probably be close to one-half the present London ADS value, or $16.33 each. The underwriters have the option of placing another $15 million of stock to cover overallotments. The transaction is scheduled to take place the week of March 14th. Yes,it looks like it's been oversubscribed.Hopef | steeplejack | |
10/3/2016 12:17 | I guess it's all about the price. Any sign what the IPO shares will be priced at. Do they have to proceed at the same as the AIM converted or can they be priced less to lure people in? | nhb001 | |
10/3/2016 11:51 | Looks as if the IPO is over-subscribed hxxp://www.globalcor | nerdofsteel | |
08/3/2016 13:51 | The NASDAQ IPO website has been updated in the last few minutes with an expected IPO date of the 17th March | nerdofsteel | |
08/3/2016 13:48 | Looking at the Beigene timetable, looks very much like we are in the final stages now, and for the first time, we now appear on the NASDAQ Upcoming IPO page Now the ADR's are priced it is a matter of a few days | nerdofsteel | |
08/3/2016 12:45 | It's from this site , presumably , although a few other US ipo sites have the same data. I doubt very much it will be next week , but I'll be happy to be proved wrong. hxxp://www.renaissan | miti 1000 | |
08/3/2016 08:14 | Hi Nerdofsteel - I wasn't aware that the IPO was scheduled for next week - can I ask where you have seen this info | jatin724 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions